Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 ...

Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ...

View Sinovac Biotech Ltd. SVA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Sinovac Biotech ( (SVA)) has shared an announcement. Sinovac Biotech Ltd., a ...

BEIJING, May 21, 2026--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has extended ...

Intends to file definitive proxy materials in the coming days SINOVAC’s Board of Directors (the “SINOVAC Board”) also issued a letter to shareholders. The full text of the letter follows: Dear SINOVAC ...

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today sent shareholders ...

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

(RTTNews) - China-based SINOVAC Biotech Ltd. (SVA) Monday announced that its Board of Directors has alerted shareholders to a new lawsuit by Advantech/Prime Success, which threatens to prevent payment ...